Northrop Grumman: Underwhelming Near-Term Growth, But F/A-XX Could Reset the Trajectory
Northrop Grumman beat Q4 2025 estimates, but conservative 2026 guidance (4% revenue growth, flat free cash flow) leaves limited upside at current valuations. The trade idea: a tactical long that captures upside if F/A-XX or similar high-profile contract momentum returns, while protecting against guidance-driven weakness.